News
Gilead’s Livdelzi Shows Lasting Efficacy in Primary Biliary Cholangitis, Regardless of Prior Therapy
Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...
The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.
In an effort to combat the state’s shortage of primary care physicians, Blue Cross Blue Shield of Massachusetts is offering ...
Founder and CEO of Alume Biosciences, Quyen Nguyen, MD, PhD, discusses nerve regeneration, nerve visualization and the reason behind what she does at Alume Biosciences.
Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...
Top-line results from two pivotal Phase III trials found that MR-107A-02 significantly reduced pain intensity following ...
The idea of creating a gray zone in the payer message is to take the onus off of having to heavily discount for equal access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback